Huron Consulting Group Inc. (NASDAQ:HURN) Shares Sold by Schonfeld Strategic Advisors LLC

Schonfeld Strategic Advisors LLC reduced its stake in Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) by 43.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,450 shares of the business services provider's stock after selling 1,880 shares during the period. Schonfeld Strategic Advisors LLC's holdings in Huron Consulting Group were worth $304,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Allspring Global Investments Holdings LLC lifted its holdings in shares of Huron Consulting Group by 61.3% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 11,972 shares of the business services provider's stock worth $1,488,000 after acquiring an additional 4,550 shares during the last quarter. Aigen Investment Management LP bought a new stake in shares of Huron Consulting Group during the 4th quarter worth $211,000. Congress Asset Management Co. boosted its holdings in shares of Huron Consulting Group by 9.0% in the 4th quarter. Congress Asset Management Co. now owns 79,095 shares of the business services provider's stock worth $9,828,000 after buying an additional 6,521 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Huron Consulting Group by 29.6% in the 4th quarter. JPMorgan Chase & Co. now owns 101,041 shares of the business services provider's stock valued at $12,555,000 after acquiring an additional 23,059 shares during the period. Finally, PEAK6 LLC bought a new stake in shares of Huron Consulting Group during the fourth quarter valued at about $230,000. Institutional investors own 93.90% of the company's stock.

Insider Activity at Huron Consulting Group

In related news, Director John Mccartney sold 500 shares of the business's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $151.13, for a total value of $75,565.00. Following the transaction, the director now owns 55,688 shares in the company, valued at $8,416,127.44. The trade was a 0.89% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director James H. Roth sold 8,641 shares of the business's stock in a transaction dated Wednesday, March 26th. The shares were sold at an average price of $142.38, for a total value of $1,230,305.58. Following the completion of the transaction, the director now owns 47,638 shares in the company, valued at $6,782,698.44. This trade represents a 15.35% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 76,239 shares of company stock worth $11,168,801. Company insiders own 2.15% of the company's stock.

Huron Consulting Group Stock Performance

Shares of HURN traded up $4.88 during mid-day trading on Friday, reaching $152.93. The company had a trading volume of 249,010 shares, compared to its average volume of 149,725. Huron Consulting Group Inc. has a 52-week low of $84.87 and a 52-week high of $155.00. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.82. The stock has a market capitalization of $2.64 billion, a P/E ratio of 33.25 and a beta of 0.23. The stock has a 50 day moving average of $143.56 and a two-hundred day moving average of $132.91.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last announced its earnings results on Tuesday, April 29th. The business services provider reported $1.68 EPS for the quarter, beating analysts' consensus estimates of $1.16 by $0.52. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. The business had revenue of $404.14 million during the quarter, compared to analysts' expectations of $389.27 million. During the same quarter in the prior year, the firm earned $1.23 earnings per share. The business's revenue was up 11.2% compared to the same quarter last year. On average, analysts expect that Huron Consulting Group Inc. will post 6.1 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on HURN shares. Benchmark reaffirmed a "buy" rating and issued a $165.00 target price on shares of Huron Consulting Group in a research note on Wednesday, March 26th. Barrington Research increased their price objective on Huron Consulting Group from $167.00 to $173.00 and gave the company an "outperform" rating in a research report on Monday, May 5th. Truist Financial raised their price objective on Huron Consulting Group from $165.00 to $180.00 and gave the stock a "buy" rating in a research note on Tuesday, March 4th. Wedbush lifted their target price on Huron Consulting Group from $150.00 to $165.00 and gave the company an "outperform" rating in a research note on Wednesday, March 26th. Finally, StockNews.com cut Huron Consulting Group from a "buy" rating to a "hold" rating in a report on Friday, May 2nd. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $170.75.

Huron Consulting Group Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.